Open Access
Ann Toxicol Anal
Volume 24, Number 2, 2012
Page(s) 87 - 96
Published online 22 June 2012
  1. Kintz P, Cirimele V, Villain M, Tracqui A, Ludes B. Soumission chimique : approches pratiques en toxicologie médico-légale. Annal Toxicol Anal. 2002; 14 : 361–364. [CrossRef] [EDP Sciences]
  2. Humbert L, Grisel F, Richeval C, Lhermitte M. Screening of xenobiotics by ultra-performance liquid chromatography-mass spectrometry using in-source fragmentation at increasing cone voltages : library constitution and an evaluation of spectral stability. J Anal Toxicol. 2010; 34(9) : 571–580. [PubMed]
  3. Kintz P. Soumission chimique : prise en charge toxicologique. Ann Toxicol Anal. 2003; 15 : 239–242. [CrossRef] [EDP Sciences]
  4. Gaulier JM, Fonteau F, Jouanel E, Lachâtre G. Les substances de la soumission chimique : aspects pharmacologiques et analytiques. Annal Biol Clin. 2004; 62(5) : 529–538.
  5. Dumestre-Toulet V, Verstraete A. Hallucinogènes et Internet ou le cyberspace psychédélique. Toxicorama. 1998; 10 : 98–105.
  6. ElSohly MA, Salamone SJ. Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol. 1999; 23 : 141–146. [CrossRef] [PubMed]
  7. Hindmarch I, ElSohly M, Gambles J, Salamone S. Forensic urinalysis of drug in cases of alleged sexual assault. J Clin Forensic Med. 2001; 8 : 197–205. [CrossRef] [PubMed]
  8. Questel F, Diament-Berger O, Lagier G. Soumission médicamenteuse : analyse d’une série de résultats toxicologiques urinaires. Ann Toxicol Anal. 2001; 13 : 121–122.
  9. Questel F, Lagier G, FoDjezzra D, Dally S, Elkaharrat D, Diamant-Berger O. Usage criminel de produits psychoactifs : analyse d’une série parisienne. Ann Toxicol Anal. 2002; 14 : 371–380. [CrossRef] [EDP Sciences]
  10. Enquête soumission chimique, Agence française de sécurité sanitaire des produits de santé. Document consulté sur le site en juillet 2003.
  11. Kintz P. Éditorial : la soumission chimique. Ann Toxicol Anal. 2002; 14(4) : 359.
  12. Negrusz A, Gaensslen RE. Analytical developments in toxicological investigation of drug-facilitated sexual assault. Anal Bioanal Chem. 2003; 376(8) : 1192–1197. [CrossRef] [PubMed]
  13. Juhascik M, Le NL, Tomlinson K, Moore C, Gaensslen RE, Negrusz A. Development of an analytical approach to the specimens collected from victims of sexual assault. J Anal Toxicol. 2004; 28(6) : 400–406. [PubMed]
  14. Quintela O, Sauvage FL, Charvier F, Gaulier JM, Lachâtre G, Marquet P. Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine : method with forensic applications. Clin Chem. 2006; 52(7) : 1346–1355. [CrossRef] [PubMed]
  15. Pépin G. Aspects analytique, toxicologique, judiciaire de la soumission chimique : dix ans d’expérience. Ann Pharm Fr. 2010; 68(2) : 61–75. [CrossRef] [PubMed]
  16. Ishida T, Kudo K, Hayashida M, Ikeda N. Rapid and quantitative screening method for 43 benzodiazepines and their metabolites, zolpidem and zopiclone in human plasma by liquid chromatography/mass spectrometry with a small particle column. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(25) : 2652–2657. [CrossRef] [PubMed]
  17. Dresen S, Ferreirós N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem. 2010; 396(7) : 2425–2434. [CrossRef] [PubMed]
  18. Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg. 2000; 55 : 323–333. [PubMed]
  19. Verstraete A. Fenêtre de détection des xénobiotiques dans le sang, les urines, la salive et les cheveux. Ann Toxicol Anal. 2002; 14(4) : 390–394. [CrossRef]
  20. Villain M, Chèze M, Tracqui A, Ludes B, Kintz P. Windows of detection of zolpidem in urine and hair : application to two drug facilitated sexual assaults. Forensic Sci Int. 2004; 143 : 157–161. [CrossRef] [PubMed]
  21. Klupsch F, Houssin R, Humbert L, Imbenotte M, Henichart JP, Lhermitte M. Major metabolites of zolpidem : expeditious synthesis and mass spectra. Chem Pharm Bull (Tokyo). 2006; 54(9) : 1318–1321. [CrossRef] [PubMed]
  22. Richeval C, Rifflet A, Humbert L, Imbenotte M, Houssin R, Lhermitte L. Élargissement de la fenêtre de détection du zolpidem par la recherche de ses métabolites urinaires dans le cadre de la soumission chimique. Ann Toxicol Anal. 2008; 20(2) : 79–83. [CrossRef]
  23. Ojanpera S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanpera I. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time of flight mass spectrometry. Rapid Commun Mass Spectrom. 2006; 20 : 1161–1167. [CrossRef] [PubMed]
  24. ElSohly MA, Gul W, Murphy TP, Avula B, Khan IA. LC-(TOF) MS analysis of benzodiazepines in urine from alleged victims of drug-facilitated sexual assault. J Anal Toxicol. 2007; 31 : 505–514. [CrossRef] [PubMed]
  25. Polettini A, Gottardo R, Pascali JP, Tagliaro F. Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionization-time-of flight mass spectrometry. Anal Chem. 2008; 80 : 3050–3057. [CrossRef] [PubMed]
  26. Kaufmann A, Butcher P, Maden K, Widmer M. Ultra-performance liquid chromatography coupled to time of flight mass spectrometry (UPLC-TOF) : a novel tool for multiresidue screening of veterinary drugs in urine. Anal Chim Acta. 2007; 586 : 13–21. [CrossRef] [PubMed]
  27. Kolmonen M, Leinonen A, Pelander A, Ojanpera I. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time of flight mass spectrometry. Anal Chim Acta. 2007; 585 : 94–102. [CrossRef] [PubMed]
  28. Baselt RC. Disposition of drugs and chemicals in Man, Sixth edition Biomedical Publication, 2002 : 116–117.
  29. Dictionnaire VIDAL 2011, 87e édition.
  30. Hewick DS, Beckett AH. The metabolism in vitro of phenothiazine drugs. Biochem J. 1971; 122(5) : 59–60. [PubMed]
  31. Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 2006; 8(1) : 101–111. [CrossRef]
  32. Sauvage FL, Gaulier JM, Lachâtre G, Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin Chem. 2008; 54(9) : 1519–1527. [CrossRef] [PubMed]
  33. Sauvage FL, Picard N, Saint-Marcoux F, Gaulier JM, Lachâtre G, Marquet P. General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology : applications and constraints. J Sep Sci. 2009; 32(18) : 3074–3083. [CrossRef] [PubMed]
  34. Beaune P. Human cytochromes P450. Applications in pharmacology. Therapie. 1993; 48(6) : 521–526.
  35. Beaune P, Guengerich FP. Human drug metabolism in vitro. Pharmacol Ther. 1988; 37(2) : 193–211. [CrossRef] [PubMed]